CHF
The second-generation dihydropyridines were expected to be of more value,       and of all the calcium channel blockers, these drugs were the ones most studied       in patients with CHF.
The second-generation dihydropyridines were expected to be of more value,       and of all the calcium channel blockers, these drugs were the ones most studied       in  @OBJECT$   @PREDICAT$   @SUBJECT$ .